RecruitingNCT05065060

Parkinson Progression Marker Initiative Online (PPMI Online)

Parkinson's Progression Markers Initiative Online Study (PPMI Online)


Sponsor

Michael J. Fox Foundation for Parkinson's Research

Enrollment

500,000 participants

Start Date

Jul 28, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

Parkinson Progression Marker Initiative Online (PPMI Online) is an observational study collecting participant reported information from people with and without Parkinson's disease (PD), for the goal of better understanding risk and predictive factors for PD. PPMI Online is part of the broader Parkinson Progression Marker Initiative aimed at identifying markers of disease progression for use in clinical trials of therapies to reduce progression of PD disability.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

PPMI Online is a large-scale online research study that tracks Parkinson's disease progression using surveys, at-home tests, and optional biosample collection. Participants with and without Parkinson's disease are welcome, helping researchers understand what changes over time in people with PD. **You may be eligible if...** - You are 18 or older - You have been diagnosed with Parkinson's disease, OR you have not been diagnosed with Parkinson's disease (as a healthy comparison participant) **You may NOT be eligible if...** - There are no major exclusion criteria — this study is broadly inclusive Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERObservation

Observation


Locations(1)

UCSF Movement Disorders and Neuromodulation Center (MDNC)

San Francisco, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05065060


Related Trials